Organización del servicio de referencia digital

64

54) Colerangle JB & Roy D. 1997. Profound effects of the weak environmental estrogen-like chemical bisphenol A on the growth of the mammary gland of Noble rats. J Steroid Biochem Mol Biol 60:153-60.

55) Newbold RR, Jefferson WN, Padilla-Banks E. 2007. Long-term adverse effects of neonatal exposureto bisphenol A on the murine female reproductive tract. Reprod Toxicol 24:253-258.

56) Murray TJ, Maffini MV, Ucci AA, Sonneschein C, Soto AM. 2007. Induction of mammary gland ductal hyperplasia and carcinoma in situ following fetal

bisphenol A exposure. Reprod Toxicol 23:383-390.

57) Signorile PG, Spugnini EP, Mita L, Mellone P, D’Avino A, Bianco M, et al. 2010. Pre-natal exposure of mice to bisphenol A elicits and endometriosis-like phenotype in female offspring. General and Comparative Endocrinol 168:318- 325.

58) The Cancer Genome Atlas Network. 2012. Comprehensive molecular portraits of human breast tumours. Nature 490, 61–70.

59) Buck Louis GM, Weiner JM, Whitcomb BW, Sperrazza R, Schisterman EF, Lobdell DT, Crickard K, Greizerstein H, Kostyniak PJ. 2005. Environmental PCB exposure and risk of endometriosis. Human Reprod 20: 279-285.

60) Heiler JF, Nackers F, Verougstraete V, Tonglet R, Lison D, Donnez J. 2005. Increased dioxin-like compounds in the serum of women with peritoneal endometriosis and deep endometriotic (adenomyotic) nodules. Fertil Steril 84: 305-312.

61) Niskar AS, Needham LL, Rubin C, Turner WE, Martin CA, Patterson DG, Hasty L, Wong LY, Marcus M. 2009 Serum dioxins, polychlorinated biphenyls, and endometriosis: A case-control study in Atlanta. Chemosphere 74:944-949.

62) Pauwels A, Schepens PJ, Hooghe TD, Delbeke I, Dhont M, Brouwer A, Weyler J. 2001. The risk of endometriosis and exposure to dioxins and polychlorinated biphenyls: a case-control study of infertile women. Human Reprod 16: 2050- 2055.

63) Porpora MG, Medda E, Abballe A, Bolli S, De Angelis I, di Domenico A, Ferro A, Ingelido AM, Maggi A, Panici PB, De Felip E. 2009. Endometriosis and organochlorinated environmental pollutants: A case-control study on Italian women of reproductive age. Env Health Perspect 117:1070-1075.

65

64) Trabert B, De Roos AJ, Schwartz SM, Peters U, Scholes D, Barr DB, Holt VL. 2010. Non-dioxin-like polychlorinated biphenyls and risk of endometriosis. Env Health Perspect 118:1280-1285.

65) Tsukino H, Hanaoka T, Sasaki H, Motoyama H, Hiroshima M, Tanaka T, Kabuto M, Niskar AS, Rubin C, Patterson Jr DG, Turner W, Needham L, Tsugane S. 2005. Associations between serum levels of selected organochlorine compunds and endometriosis in infertile Japanese women. Environ Res 99:118-125. 66) Kim SH, Chun S, Jang JY, Chae HD, Kim CH, Kang BM. 2011. Increased

plasma levels of phthalate esters in women with advanced stage endometriosis: a prospective case-control study. Fertil Steril 95: 357-359.

67) Upson K, Sathyanarayana S, De Roos AJ, Thompson ML, Scholes D, Dills R, Holt V. 2013. Phthalates and risk of endometriosis. Environ Res 126:91-97. 68) Itoh H, Iwasaki M, Hanaoka T, Sasaki H, Tanaka T, Tsugane S. 2007. Urinary

bisphenol-A concentration in infertile Japanese women and its association with endometriosis: A cross-sectional study. Env Health Prev Med 12:258-264. 69) Buck Louis GM, Peterson M, Chen Z, Croughan M, Sundaram R, Stanford J,

Warner M, Kennedy A, Gludice L, Fujimoto V, Sun L, Wang L, Guo Y, Kannan K. 2013. Bisphenol A and phthalates and endometriosis. Fertil Steril 100: 162- 169.

70) Huang PC, Tsai EM, Li WF, Liao PC, Chung MC, Wang YH, Wang SL. 2010. Association between phthalate exposure and glutathione S-transferase M1 polymorphism in adenomyosis, leiomyoma and endometriosis. Human Reprod 25:986-994.

71) Itoh H, Iwasaki M, Hanaoka T, Sasaki H, Tanaka T, Tsugane S. 2009. Urinary phthalate monoesters and endometriosis in infertile Japanese women. Sci Total Environ 408:37-42.

72) Itoh H, Iwasaki M, Nakajima Y, Endo Y, Hanaoka T, Sasaki H, Tanaka T, Yang B, Tsugane S. 2008. A case-control study of the association between urinary cadmium concentration and endometriosis in infertile Japanese women. Sci Total Environ 402:171-175.

73) Weuve J, Hauser R, Calafat AM, Missmer SA, Wise LA. 2010. Association of exposure to phthalates with endometriosis and uterine leiomyomata: Findings from NHANES, 1999-2004. Environ Health Perspect 118:825-832.

66

74) Reddy BS, Rozati R, Reddy BV, Raman NV. 2006. Association of phthalate esters with endometriosis in Indian women. Int J Obstetrics Gynaecol 113:515- 520.

75) Reddy BS, Rozati R, Reddy S, Kodampur S, Reddy P, Reddy R. 2006. High plasma concentrations of polychlorinated biphenyls and phthalate esters in women with endometriosis: a prospective case control study. Fertil and Steril 85:775-779.

76) De S, Ghosh S, Chatterjee R, Chen YQ, Moses L, Kesari A, Hoffman EP, Dutta SK. 2010. PCB congener specific oxidative stress response by microarray analysis using human liver cell line. Environ Int 36:907-917

77) Burney RO, Talbi S, Hamilton AE,Vo KC, Nyegaard M, Nezhat CR, Lessey BA, Giudice LC. 2007. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinol 148:3814-3826.

78) Hever A, Roth RB, Hevezi P, Marin ME, Acosta JA, Acosta H, Rojas J, Herrera R, Grigoriadis D, White E, Conlon PJ, Maki RA, Zlotnik A. 2007. Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator. Proc Natl Acad Sci USA 104:12451-12456. 79) Sha G, Wu D, Zhang L, Chen X, Lei M, Sun H, Lin S, Lang J. 2007.

Differentially expressed genes in human endometrial endothelial cells derived from eutopic endometrium of patients with endometriosis compared with those from patients without endometriosis. Hum Reprod 22:3159-3169.

80) Spirtes P, Glymour C and Scheines R. 2000 Causation, Prediction, and Search, 2nd ed. New York, N.Y.: MIT Press.

81) Melin A, Sparen P, Bergqvist A. 2007. The risk of cancer and the role of parity among women with endometriosis. Human Reprod 22:i27-i28.

82) Irahara N, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S. 2006. Quantitative analysis of aromatase mRNA expression derived from various promoters and its association with expression of TNF-α, IL-6 and COX-2 mRNAs in human breast cancer. Int J Cancer 118:1915–1921.

83) Roy JR, Chakraborty S, Chakraborty TR. 2009. Estrogen-like endocrine disrupting chemicals affecting puberty in humans – a review. Med Sci Monit15:RA137–RA145.

84) Ibarluzea JJ, Fernandez MF, Santa-Marina L, Olea-Serrano MF, Rivas AM, Aurrekoetxea JJ, Exposito J, Lorenzo M, TorneP, Villalobos M, Pedraza V, Sasco

67

AJ, Olea N. 2000. Breast cancer risk and the combined effect of environmental oestrogens. Cancer Causes Control 15:591-600.

85) Palmer JR, Wise LA, Hatch EE, Troisi R, Titus-Ernstoff L, Strohsnitter W, Kaufman R, Herbst AL, Noller KL, Hyer M, Hoover RN. 2006. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15:1509-1514.

86) Treeck O, Elemenler E, Kriener C, Horn F, Springwald A, Hartmann A, Ortmann O. 2009. Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility. J Steroid Biochem Mol Biol 114: 207-211.

87) Xue Q1, Lin Z, Cheng YH, Huang CC, Marsh E, Yin P, Milad MP, Confino E, Reierstad S, Innes J, Bulun SE. 2007. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod 77:681-687. 88) Bulun SE. 2009. Endometriosis. New Engl J Med 360:268-279.

89) Al Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, Pooley KA, Luccarini C, Munday H, Perkins B, Smith P, Pharoah PD, Wareham NJ, Easton DF, Ponder BA, Dunning AM. 2006. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet 15: 1–10.

90) Raulic S, Ramos-Valdes Y, DiMattia GE. 2008. Stanniocalcin 2 expression is regulated by hormone signaling and negatively affects breast cancer cell viability in vitro. J Endocrinol 197:517-529.

91) Wood CE, Kaplan JR, Fontenot MB, Williams JK, Cline JM. 2010. Endometrial profile of tamoxifen and low-dose estradiol combination therapy Clin Cancer Res 16: 946–956.

92) Gruvberger S, Ringnér M, Chen Y, Panavally S, Saal LH, Borg A, Fernö M, Peterson C, Meltzer PS. 2001. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61:5979-5984.

93) Roy D, Cai Q, Felty Q, Narayan S. 2007. Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers. J Toxicol Environ Health B Crit Rev 10:235-57.

94) Modugno F, Ness RB, Chen C, Weiss NS. 2005. Inflammation and endometrial cancer: A hypothesis. Cancer Epidemiol Biomarkers Prev14:2840–2847.

68 CHAPTER III

METHODS